Technology

Foundation - Wednesday 9 June, 2021

Samantha was born with aortic stenosis, a heart defect that occurs when the valve that allows blood to flow from the left ventricle to the aorta and the rest of the body is too narrow. At only 13 months old, Samantha underwent a procedure called a heart catheterization by balloon valvuloplasty, a very complex procedure that dilates the valve with a balloon at the tip of a catheter.

Foundation - Monday 31 May, 2021

Last August, the Foundation announced the creation of the André Chagnon Research Chair in Congenital Heart Disease. Thanks to a $2 million donation from Sojecci, this new research chair will help develop innovative approaches to the care and treatment of patients with congenital heart disease, a heart defect present from birth.

Foundation - Monday 17 May, 2021

Twins Jonathan and Marvin Gurman, both entrepreneurs, recently underwent surgery for aortic valve stenosis. After consulting with various doctors around the world about the most advanced procedures in the field, they finally found the best treatment for them in their home city of Montreal. At the Montreal Heart Institute, they met Dr. Denis Bouchard, a pioneer in minimally invasive surgery. Find out how they learned about this surgical procedure that would have a major impact on their recovery.  

Foundation - Thursday 22 April, 2021

Jacques Gendreau passed away in December 2020. He was monitored at the Institute for atrial fibrillation and a leaky heart valve. In order to thank the Institute for the excellent care he received, he chose to include a donation to the Foundation in his will. A heartfelt gesture that allows the Foundation to save more sensitive hearts.

Foundation, in collaboration with Caroline Dupré, a nurse at the Institute’s transplant clinic - Friday 9 April, 2021

Even as a child, Caroline Dupré knew she wanted to be a nurse. “Taking care of people is what’s most important to me. When I was small, I carried around a little doctor’s bag and put bandages on my dolls. You could say I figured out pretty early on that I wanted to work in a hospital.” Growing up, she set her sights on working at the Montreal Heart Institute, a dream that quickly came true.

Foundation, in collaboration with Dr. Marie-Pierre Dubé, Director of the MHI’s Beaulieu-Saucier Pharmacogenomics Centre - Wednesday 17 March, 2021

As Director of the Université de Montréal’s Beaulieu-Saucier Pharmacogenomics Centre at the Montreal Heart Institute for nearly 10 years now, she oversees a team of some 20 experts and wears several hats, including researcher, associate professor and scientific author. She loves her work and enjoys sharing that passion with others.

Foundation - Thursday 4 February, 2021

Mr. Labrie, 29, is an active, energetic, and ambitious entrepreneur with an impressive list of achievements under his belt. He has invested his body and soul in his company, he is involved within the community, and sits on several boards of directors, including the one at the Montreal Heart Institute Foundation. Hard to believe that he underwent open-heart surgery last June.

Foundation - Thursday 10 December, 2020

When three generations share the same passion, it becomes part of their DNA! Read on to discover the story of Dr. Pierre Robillard and Dr. Julie Robillard, a pair of outstanding radiologists.

Foundation, in collaboration with Dr. Serge Doucet, cardiologist and Director of Education at the Institute - Monday 21 September, 2020

Over the past few years, simulation-based education has become increasingly popular in the field of medicine. In fact, several articles have demonstrated its value and even suggested that it can reduce the number of errors made during real medical interventions. In this vein, the Institute’s Centre de formation et d’excellence en santé cardiovasculaire will soon offer new courses as part of its Simulation-based teaching program. Numerous healthcare professionals are already interested in the cardiac catheterization program.

Foundation - Monday 24 August, 2020

The Colcorona genetic study is taking place at the Montreal Heart Institute’s Beaulieu-Saucier Pharmacogenomics Centre and is led by Dr. Marie-Pierre Dubé. This study invited participants who have already accepted to take part in the Colcorona study to voluntarily contribute their DNA. The study of their DNA will help researchers better understand why some patients develop a more severe form of COVID-19.